摘要
目的 :分析乳腺癌肺转移综合治疗的疗效及影响生存的预后因素。方法 :65例乳腺癌肺转移患者采用化疗、放疗、内分泌和综合治疗 ,分单一方法治疗组和综合治疗组 ,疗效评价按WHO标准 ,生存率按寿命表法计算。结果 :单一方法治疗组总有效率为 4 6.9% ,综合治疗组总有效率为 72 .7% ,经统计学处理 ,P <0 .0 5 ;两组患者的中位生存期相近 ;内分泌治疗未能提高总有效率。结论 :乳腺癌肺转移综合治疗近期疗效明显优于单一方法治疗 。
Objective Analysis prognostic factors related to efficacy and life span of combined therapy of lung metastatic breast cancer.Methods 65 cases of patients suffered from breast cancer lung metastasis were divided into single therapy group and combined therapy group.Chemotherapy,radiotherapy and hormonal therapy were used in the therapy groups.WHO criteria was used in evaluation of efficacy.Survival rate was calculated by life span chart.Results Total efficacy rate was significantly different in two groups:46.9% in single therapy group vs. 72.7% in combined therapy group.The middle life span time were similar in two groups Hormonal therapy could not improve total efficacy rate.Conclusions Combined therapy was better than single therapy in the treatment of breast cancer lung metastasis patients.Combined therapy could not prolong the life span.Hormonal therapy was unsuitable for these patients because of the lack of estrogen receptor.
出处
《肿瘤防治杂志》
2002年第1期70-71,共2页
China Journal of Cancer Prevention and Treatment
关键词
乳腺癌
肺移植
治疗
综合疗法
lung neoplasms/secondary
lung neoplasms/therapy
breast neoplasms/therapy
combined modality therapy
